Deepshikha Charan Ashana1,2, Noah D'Arcangelo3, Priscilla K Gazarian4, Avni Gupta4,5, Stephen Perez4, Amanda J Reich4, Jennifer Tjia6, Scott D Halpern2,7,8, Joel S Weissman4, Keren Ladin3,9. 1. Division of Pulmonary, Allergy, & Critical Care Medicine, Department of Medicine, Duke University, Durham, North Carolina, USA. 2. Palliative and Advanced Illness Research (PAIR) Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA. 3. Research on Ethics, Aging, and Community Health (REACH Lab), Tufts University, Medford, Massachusetts, USA. 4. Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, Massachusetts, USA. 5. Department of Public Health Policy and Management, School of Global Public Health, New York University, New York, USA. 6. Division of Epidemiology, Department of Population and Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, USA. 7. Division of Pulmonary, Allergy, & Critical Care Medicine, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA. 8. Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, USA. 9. Department of Occupational Therapy and Community Health, Tufts University, Medford, Massachusetts, USA.
Abstract
BACKGROUND: Structurally marginalized groups experience disproportionately low rates of advance care planning (ACP). To improve equitable patient-centered end-of-life care, we examine barriers and facilitators to ACP among clinicians as they are central participants in these discussions. METHOD: In this national study, we conducted semi-structured interviews with purposively selected clinicians from 6 diverse health systems between August 2018 and June 2019. Thematic analysis yielded themes characterizing clinicians' perceptions of barriers and facilitators to ACP among patients, and patient-centered ways of overcoming them. RESULTS: Among 74 participants, 49 (66.2%) were physicians, 16.2% were nurses, and 13.5% were social workers. Most worked in primary care (35.1%), geriatrics (21.1%), and palliative care (19.3%) settings. Clinicians most frequently expressed difficulty discussing ACP with certain racial and ethnic groups (African American, Hispanic, Asian, and Native American) (31.1%), non-native English speakers (24.3%), and those with certain religious beliefs (Catholic, Orthodox Jewish, and Muslim) (13.5%). Clinicians were more likely to attribute barriers to ACP completion to patients (62.2%), than to clinicians (35.1%) or health systems (37.8%). Three themes characterized clinicians' difficulty approaching ACP (preconceived views of patients' preferences, narrow definitions of successful ACP, and lack of institutional resources), while the final theme illustrated facilitators to ACP (acknowledging bias and rejecting stereotypes, mission-driven focus on ACP, and acceptance of all preferences). CONCLUSIONS: Most clinicians avoided ACP with certain racial and ethnic groups, those with limited English fluency, and persons with certain religious beliefs. Our findings provide evidence to support development of clinician-level and institutional-level interventions and to reduce disparities in ACP.
BACKGROUND: Structurally marginalized groups experience disproportionately low rates of advance care planning (ACP). To improve equitable patient-centered end-of-life care, we examine barriers and facilitators to ACP among clinicians as they are central participants in these discussions. METHOD: In this national study, we conducted semi-structured interviews with purposively selected clinicians from 6 diverse health systems between August 2018 and June 2019. Thematic analysis yielded themes characterizing clinicians' perceptions of barriers and facilitators to ACP among patients, and patient-centered ways of overcoming them. RESULTS: Among 74 participants, 49 (66.2%) were physicians, 16.2% were nurses, and 13.5% were social workers. Most worked in primary care (35.1%), geriatrics (21.1%), and palliative care (19.3%) settings. Clinicians most frequently expressed difficulty discussing ACP with certain racial and ethnic groups (African American, Hispanic, Asian, and Native American) (31.1%), non-native English speakers (24.3%), and those with certain religious beliefs (Catholic, Orthodox Jewish, and Muslim) (13.5%). Clinicians were more likely to attribute barriers to ACP completion to patients (62.2%), than to clinicians (35.1%) or health systems (37.8%). Three themes characterized clinicians' difficulty approaching ACP (preconceived views of patients' preferences, narrow definitions of successful ACP, and lack of institutional resources), while the final theme illustrated facilitators to ACP (acknowledging bias and rejecting stereotypes, mission-driven focus on ACP, and acceptance of all preferences). CONCLUSIONS: Most clinicians avoided ACP with certain racial and ethnic groups, those with limited English fluency, and persons with certain religious beliefs. Our findings provide evidence to support development of clinician-level and institutional-level interventions and to reduce disparities in ACP.
Authors: Robert Y Lee; Lyndia C Brumback; Seelwan Sathitratanacheewin; William B Lober; Matthew E Modes; Ylinne T Lynch; Corey I Ambrose; James Sibley; Kelly C Vranas; Donald R Sullivan; Ruth A Engelberg; J Randall Curtis; Erin K Kross Journal: JAMA Date: 2020-03-10 Impact factor: 56.272
Authors: Alexander K Smith; Ellen P McCarthy; Elizabeth Paulk; Tracy A Balboni; Paul K Maciejewski; Susan D Block; Holly G Prigerson Journal: J Clin Oncol Date: 2008-09-01 Impact factor: 44.544
Authors: Lauren Jodi Van Scoy; Michael J Green; Pamela D Witt; Cindy Bramble; Christopher Richardson; Irene Putzig; Olubukola Toyobo; Emily Wasserman; Vernon M Chinchilli; Amy Tucci; Benjamin H Levi Journal: J Gen Intern Med Date: 2020-09-18 Impact factor: 5.128
Authors: Naoka Murakami; Nathan D Baggett; Margaret L Schwarze; Keren Ladin; Andrew M Courtwright; Hilary J Goldberg; Eric P Nolley; Nelia Jain; Michael Landzberg; Kirsten Wentlandt; Jennifer C Lai; Myrick C Shinall; Nneka N Ufere; Christopher A Jones; Joshua R Lakin Journal: J Palliat Med Date: 2022-03-11 Impact factor: 2.947